Clinical Trial Update: A Study of Participants With Initially Unresectable Hepatocellular Carcinoma That is Treated With Atezolizumab and Bevacizumab Plus Transarterial Chemoembolization

View source ↗

Summary

This clinical trial update reports on a completed study evaluating the combination of atezolizumab and bevacizumab with transarterial chemoembolization in parti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Atezolizumab (atezolizumab)
• Bevacizumab (bevacizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Unresectable Hepatocellular Carcinoma | Status: COMPLETED